Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's Colitis

Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's Colitis - IFX in feces

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37225

Enrollment

Registered

2012-12-04

Start date

2012-12-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -patients (>18 years) with Ulcerative Colitis or Crohn's Colitis who start on Infliximab therapy

Exclusion criteria

Exclusion criteria: History of previous Infliximab use

Design outcomes

Primary

Measure	Time frame
IFX level in feces	—

Countries

Netherlands

Outcome results